Positive UBT findings were obtained in 40.6 % of included subjects. The sensitivities and the specificities of Vidas, Chorus and Genedia were 89.7 %, 100 % and 100 % and 85.5 %, 75.4 % and 80.7 %, respectively.
INTRODUCTION
Several non-invasive tests, which do not require endoscopy, have been developed to establish whether a patient is infected with Helicobacter pylori. The serum anti-H. pylori immunoglobulin G (IgG) antibody test, which is both simple and inexpensive, is one of these tests (Burucoa et al., 2013; Faigel et al., 2000) . Although it cannot distinguish between active and recently treated infections, serology is more accurate than biopsy in endemic areas of H. pylori infection and gastric cancer. This is due to the increased likelihood of false negative results with invasive tests in patients having severe gastric atrophy and/or intestinal metaplasia (Korstanje et al., 2008) .
Various commercial enzyme-immunoassays (EIAs), including ELISA kits, are now available and are considered to be a reliable and valid method for detection of gastric colonization by H. pylori. However, there is some debate on the overall performance of H. pylori diagnostic kits from particular geographical regions. For example, a Chinese study found that Western commercial serological tests performed poorly when used in Chinese patients (Leung et al., 1999) . Despite the high accuracy of these tests reported in the West, they yielded variable diagnostic performance in other regions, possibly due to strain-specific differences in serum anti-H. pylori IgG antibody responses in different populations (Marchildon et al., 2003) . Conversely, a recent Chinese study showed that a Western serology test was reliable for screening H. pylori infection in Chinese populations (Ren et al., 2005) .
Serology tests that were developed in Western countries are widely performed in Korea. However, it has been shown that Koreans and their Western counterparts differ in regard to the types of H. pylori they harbour, with Koreans showing a high prevalence of the East Asian CagA type (Lee, 2012 (Lee, , 2014 Seo et al., 2011) . Therefore, serological assays should be validated in each population and a consensus report also stated that only validated commercial tests should be used (Malfertheiner et al., 2012) . Despite this, most serological assays used in Korea are not validated in Asian populations and have not been directly compared to Korean assays for detection of H. pylori antigen in Korea, where the prevalence of gastric cancer is the highest in the world. Therefore, we aimed to validate and compare the diagnostic accuracy of Korean and Western serological assays for H. pylori detection in Korean adults. estimated that the sensitivity (or specificity) of the evaluated kits is 90 % (P50.9) with a 95 % confidence interval (Burucoa et al., 2013 Subjects. Korean adults who visited our centre between January and June of 2014 for the evaluation of H. pylori infection using the urea breath test (UBT) were included in this prospective study. The inclusion criteria were Koreans over 16 years old who had completed UBT and blood sampling on the same day at our centre. Subjects were excluded when they had a recent history of medication, including H. pylori eradication, within the previous 6 months. Other exclusion criteria were the presence of significant disease that required treatment, pregnancy, lactation or incomplete data in any of the performed tests.
Informed consent was obtained and the study was approved by the institutional review board (IRB) of Konkuk University School of Medicine, which confirmed that it was in accordance with the ethical guidelines of the Helsinki Declaration. After the approval, this study was registered as ClinicalTrials.gov ID: KCT0001187 (https://cris.nih.go.kr).
Serum anti-H. pylori antibody test. Blood samples were obtained from each participant after 8 h of fasting. These were subjected to centrifugation, and serum was stored at 270 uC prior to analysis. Serum levels of anti-H. pylori IgG antibodies were measured using three commercially available immunoassays: Genedia H. pylori ELISA (Green Cross Medical Science), Chorus H. pylori IgG (DIESSE Diagnostica Senese) and Vidas H. pylori IgG (bioMérieux). All three tests were performed using the same blood sample, according to the manufacturer's instructions.
Genedia H. pylori ELISA test. The Genedia kit is an ELISA that uses peroxidase-conjugated anti-human IgG. This assay uses H. pylori antigen obtained from Korean H. pylori strains. The cut-off value for this kit was defined as mean absorbance of the negative control +0.4 OD at 450 nm, as specified in the manufacturer's instructions. The sensitivity and specificity of this assay in Korean adults have been reported as 97.8 % and 92.0 %, respectively (Kim et al., 1998) .
Chorus H. pylori IgG test. For the Chorus H. pylori IgG assay, H. pylori antigen-specific immunoglobulins are bound to solid phase and detected by peroxidase-conjugated anti-human IgG monoclonal antibodies. The titre was expressed in AU (arbitrary units); sample IgG concentrations .12 AU were considered positive, and those ,8 AU were considered negative. The samples between these cut-off levels were considered equivocal. The manufacturer's reported sensitivity and specificity are were 89 % (95 % confidence interval [CI]: 77-95 %) and 100 % (95 % CI: 92-100 %), respectively. A study from Italy found that, in Italian adults, this assay displayed a sensitivity and specificity of 95 % and 100 %, respectively (Figura et al., 1994) .
Vidas H. pylori IgG test. The Vidas H. pylori IgG assay, which utilizes the enzyme immunoassay sandwich method, is combined with a final fluorescent detection and thus is described as an enzymelinked fluorescent assay. During the final detection step a relative fluorescent value (RFV) was calculated, and the test value (TV) was obtained by dividing the sample RFV by standard RFV. The result was considered positive when TV ¢1.00 and negative when TV ,0.75. The samples between these cut-off levels were considered equivocal. The manufacturer's claimed sensitivity and specificity for the Vidas H. pylori IgG test are 98.1 % (95 % CI: 93.1-99.8 %) and 90.82 % (95 % CI: 83.3-95.7 %), respectively.
Definitive diagnosis for H. pylori infection. The gold standard for H. pylori infection in this study was the UBT. It was conducted in the fasting state on the same day as the blood sampling for the serological assays, according to the manufacturer's instructions. Briefly, 100 mg of C 13 urea packed into a capsule was ingested by each patient, and exhaled breath samples were analysed using Heliview mass spectrometry (Medichems). Breath samples at baseline and 30 min after If all three serology tests and the UBT were positive, the subject was classified as having a definite H. pylori infection. If all of the tests were negative, the subject was classified as having no infection. In subjects who showed discrepancies between the three serology tests, those with a positive UBT were defined as likely to have an infection and those with a negative UBT were classified as unlikely to have an infection.
Statistical analysis. Sensitivity, specificity, positive predictive values and negative predictive values were calculated based on confirmation of H. pylori infection status using the UBT. Values were expressed as a percentage, with 95 % CI, and a P-value ,0.05 was considered statistically significant. Statistical analysis was performed using MedCalc Statistical Software (version 11.2.1, MedCalc Software). McNemar's test was used to calculate the statistical difference between assays. Continuous variables were summarized as mean± SD, and categorical variables were expressed as frequency (%). Agreement between assays was assessed using Cohen's kappa coefficient. Poor agreement was reported when the kappa value was ,0.4, while excellent agreement was reported when the kappa value was .0.75. Kappa values between 0.4 and 0.75 were reported as fair to good agreement (Malfertheiner et al., 2012) . Equivocal results of Vidas and Chorus were considered negative for analysis.
We determined that 100 samples with estimated prevalence of 50 % were required to achieve 80 % power, in order to detect a difference of 0.1000 between a diagnostic test with an area under the ROC curve (AUC) of 0.8000 and another diagnostic test with an AUC of 0.9000 using a twosided z-test at a significance level of 0.0500. The data were discrete (rating scale) responses. The AUC was computed between false-positive rates of 0.000 and 1.000. The ratio of the SD of the responses in the negative group to the SD of the responses in the positive group for diagnostic test 1 was 1.000 and for diagnostic test 2 was 1.000. The correlation between the two diagnostic tests was assumed to be 0.600 for both positive and negative groups (Obuchowski & McClish, 1997) . All analyses were conducted using PASS (http://www.ncss.com/software/pass).
RESULTS

Subject characteristics
Of the 114 subjects who visited our centre for evaluation, 18 were excluded due to a recent history of H. pylori eradication or other medication. Positive UBT findings were obtained for 39 (40.6 %) of the 96 included subjects (Table 1) . Thirty-five subjects (36.5 %) showed positive findings in all three serological tests and UBT, whereas 39 subjects (40.6 %) showed negative findings in all three serological tests and UBT. There were four subjects (34-, 36-, 42-and 61-year-old males) who tested negative by UBT but gave positive findings in all three serological tests.
Comparison of serological assays using UBT as the predefined gold standard
The sensitivities and the specificities of Vidas, Chorus and Genedia were 89.7 %, 100 % and 100 % and 85.5 %, 75.4 % and 80.7 %, respectively (Table 2 ). There were no differences in sensitivity between the Vidas and Chorus (P50.125), Chorus and Genedia (P50.125) and Vidas and Genedia (P51.000) assays. In addition, there were no differences in specificity between the Vidas and Chorus (P50.070), Chorus and Genedia (P50.508) and Vidas and Genedia (P50.549) assays. Weighted kappa values of Vidas, Chorus and Genedia for concordance with UBT were 0.741, 0.714 and 0.773, respectively, and did not differ significantly (Table 2) .
Concordance rates among the three serological tests
Weighted kappa values for concordance rates between the Vidas and Chorus, Chorus and Genedia and Genedia and Vidas assays were 0.747 (0.617-0.878), 0.812 (0.695-0.929) and 0.683 (0.537-0.828), respectively. Pairwise comparison of ROC curves showed that there were no statistically significant differences between Vidas and Chorus (P50.659), Genedia and Vidas (P50.810) and Chorus and Genedia (P50.483), as shown in Fig. 1 .
Subjects showing discrepancy between the diagnostic tests
Only 18 of the 96 subjects included in this study showed discrepancy in the results of the three serology tests (Table 3) .
Of the three tests, only Vidas gave a false-negative finding in four subjects who tested positive by UBT. The titres measured by Vidas were between 0.7 and 0.99 (one negative and three equivocal) in these four subjects.
Of the 14 samples that tested negative by UBT, falsepositives were obtained by Chorus in ten cases, by Genedia in seven cases and by Vidas in four cases. All four Vidas false-positives had low titres, measuring between 1.02 and 1.15 TV. Similarly, the ten samples that gave false-positive results in the Chorus assay exhibited low titres, giving values of between 18.0 and 108 AU, and the seven Genedia positives showed variable OD values.
DISCUSSION
In this study, we found that the diagnostic accuracy of the three serological assays for detection of H. pylori did not differ relative to the UBT findings. Notably, there were no differences in sensitivity and specificity among Genedia, Chorus and Vidas assays. In most of the subjects the three serology tests showed results consistent with UBT, suggesting that all of three of these non-invasive assays are reliable for serodiagnosis in Korean individuals.
Here we measured only IgG antibodies, as it has been shown that IgM and IgA antibodies do not perform as well in the detection of H. pylori (Laheij et al., 1998; Talley et al., 1991) . We recently showed that serum anti-H. pylori IgG antibodies are also useful in assessing the risk of gastric neoplasia and predicting pathology type in Korean adults (Choi et al., 2014) . Of the 3328 participants included in this previous study, the incidence of gastric neoplasia was highest in the gastric atrophy (+)/H. pylori (2) group (4.17 %; odds ratio 25.8, P50.009), but the neoplasm exhibited the least advanced histology using the IgG serology test. Importantly, in this previous study we could not confirm whether there was a difference between Western and Korean serology kits (Choi et al., 2014) because the Genedia H. pylori ELISA test, which utilizes H. pylori antigen obtained from Korean strains, was not tested. In our current study, we found a high concurrence rate among the three serological tests with each displaying similar diagnostic accuracies. Our findings are consistent with another recent report which demonstrated that Western serology testing can provide a reliable method for screening of H. pylori infection in Chinese populations (Ren et al., 2005) . Although a meta-analysis also found that a similar overall accuracy of common commercial serological kits (Loy et al., 1996) , studies from China and Japan have shown poor performance of Western commercial serological tests when used in Asian subjects (Leung et al., 1999; Marchildon et al., 2003; Miwa et al., 2000) . These results may due to the use in Western kits of H. pylori antigens that are less prevalent in East Asians (Miwa et al., 2000) , as antigen composition will vary according to the different strains utilized in the generation of a particular serological assay (Marchildon et al., 2003) . Therefore, Western serological assays should be validated in Asians where the prevalence of H. pylori infection and gastric cancer is high. Importantly, prior to this study, the Vidas and Chorus assays had not been validated in Asians while various Western kits were evaluated in previous studies. Also, these assays had not been directly compared to Korean serological assay in Korean individuals. The Vidas H. pylori IgG test uses a pool of native purified antigens derived from five different strains (ATCC 53721, 53722, 53725, 53726, and 53727) , and the Chorus H. pylori IgG test also uses H. pylori G21 and G39 cells as antigens. Antigens in these Western kits are prepared from diverse strains and represent various antigens, including both commo and strain-specific. Moreover, the prevalence of the East Asian CagA subtype was found to be 94.4 % in our population according to a previous report from our institution, suggesting that the majority of Koreans are infected with the East Asian CagA subtype of H. pylori (Seo et al., 2011) . Less diversity in our population may partly explain this discrepancy in results among studies.
It is notable that the three serological assays showed different diagnostic trends as compared with UBT. For example, Vidas had a tendency to give more false-negative findings, whereas Chorus had a tendency to give more false-positives. Adjustment of the cut-off level could enhance the performance of each assay according to test purposes. For example, all four The differential sensitivities and specificities obtained in various studies with the same kit indicate that it is more important to test a kit in a particular study population than to choose any specific kit (Jensen et al., 1993) . Of the 14 UBT negative subjects, ten tested positive with the Chorus assay, indicating that among the three serology tests, the false positive rate was highest in Chorus. Of these ten subjects, three showed false-positive results with the Vidas test, albeit with relatively low titres between 1.11 and 1.15. Since these three subjects also showed low titres in the Chorus assay, between 18.2 and 40.4 AU, past infection or spontaneous regression of H. pylori might be the reason for false-positives in these cases. Conversely, serum from the four subjects who showed false-positives in both the Chorus and Genedia tests showed a wide range of titres, from 0.498 to 1.720 OD for Genedia, and from 18.0 to 108 AU for Chorus. Taken together, these data suggest that recommendations for the optimal use of different interpretation criteria should be made for each serology test.
13 C-UBT was used as the gold standard in this study because there is no single test that suffices as a criterion standard to detect H. pylori infection. Although UBT is considered to be one of the most reliable tests, it is not always accurate due to the various optimal cut-off values of 13 C-UBT. The presence of four subjects who tested negative by UBT but gave positive findings in all three serological tests in our study suggests a high probability of falsenegative findings by UBT under cryptic conditions. Our data suggest that the cut-off values for each test are the most important factor when evaluating the correlation and diagnostic accuracy of commonly used tests in Koreans.
In conclusion, the Genedia H. pylori ELISA, Chorus helicobacter IgG and Vidas H. pylori IgG assays exhibited a high concurrence rate, with similar diagnostic accuracy, in Korean adults. Therefore, all three of these non-invasive assays are reliable for serodiagnosis in the Korean population.
